>>My guess is that ipi will be all but dead by the end of 2010 and the company will focus on PD-1 combinations with Provenge instead.<<
With all due respect, could you elaborate on the pessimistic view on ipi? I disagree completely. Trust me, BMY does not want touch cancer vaccine not even with a 10000-foot pole.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.